AA
ABBV icon

Addison Advisors’s AbbVie ABBV Stock Holding History

Addison Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Buy
4,818
+1
+0% +$222 0.23% 79
2025
Q4 		$1.1M Buy
4,817
+10
+0.2% +$2.28K 0.25% 76
2025
Q3 		$1.11M Buy
4,807
+78
+2% +$15.9K 0.26% 75
2025
Q2 		$878K Buy
4,729
+60
+1% +$11.2K 0.22% 83
2025
Q1 		$978K Sell
4,669
-10
-0.2% -$1.94K 0.27% 66
2024
Q4 		$831K Sell
4,679
-113
-2% -$20.8K 0.23% 74
2024
Q3 		$946K Sell
4,792
-302
-6% -$56.4K 0.26% 68
2024
Q2 		$874K Buy
5,094
+146
+3% +$24.2K 0.28% 67
2024
Q1 		$901K Buy
4,948
+429
+9% +$73.9K 0.31% 67
2023
Q4 		$700K Sell
4,519
-109
-2% -$15.9K 0.27% 70
2023
Q3 		$690K Buy
4,628
+170
+4% +$25K 0.32% 65
2023
Q2 		$601K Sell
4,458
-11
-0.2% -$1.61K 0.3% 68
2023
Q1 		$712K Buy
4,469
+227
+5% +$34.7K 0.4% 56
2022
Q4 		$686K Sell
4,242
-241
-5% -$37K 0.41% 52
2022
Q3 		$602K Sell
4,483
-4
-0.1% -$574 0.37% 55
2022
Q2 		$687K Sell
4,487
-46
-1% -$7.03K 0.42% 52
2022
Q1 		$735K Buy
4,533
+1,372
+43% +$199K 0.4% 57
2021
Q4 		$428K Buy
3,161
+705
+29% +$83.3K 0.26% 73
2021
Q3 		$265K Buy
2,456
+6
+0.2% +$686 0.21% 64
2021
Q2 		$276K Buy
+2,450
New +$276K 0.22% 63
2020
Q4 		$284K Buy
+2,650
New +$255K 0.27% 60

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Addison Advisors's ABBV Position: Q1 2026 in Review

Addison Advisors increased its AbbVie (ABBV) stake by 0.02% in Q1 2026, buying an estimated $222 and bringing the position to 4,818 shares worth $1.05M. The position accounts for 0.23% of the portfolio, ranked #79.

Addison Advisors first reported a position in ABBV in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.11M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Addison Advisors held 4,818 shares of AbbVie worth $1.05M as of Q1 2026.
  • Addison Advisors bought 1 AbbVie share in Q1 2026, an estimated $222.
  • AbbVie made up 0.23% of Addison Advisors's portfolio in Q1 2026, its #79 holding.
  • Addison Advisors first reported a position in AbbVie in Q4 2020 and has held it in 21 quarters since.
  • Addison Advisors's AbbVie position peaked at $1.11M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Addison Advisors's 13F filing for Q1 2026, filed 8 May 2026.